Pharming (PHAR) Free Cash Flow (2019 - 2026)

Pharming (PHAR) has 7 years of Free Cash Flow data on file, last reported at $11.5 million in Q4 2025.

• Quarterly Free Cash Flow rose 1239.9% year-over-year to $11.5 million in Q4 2025, while the trailing twelve-month figure through Jun 2026 was $11.5 million (up 25.85% YoY) and the FY2025 annual result came in at $54.0 million, up 2179.34% from the prior year.
• Free Cash Flow advanced to $11.5 million in Q4 2025, from -$1.0 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $13.0 million in Q3 2022 to a low of -$31.4 million in Q2 2023.
• A 5-year average of -$170275.0 and a median of $2.2 million in 2022 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2022 — Free Cash Flow jumped 1643.52% — and 2023, when it sank 2041.86%.
• Tracing PHAR's Free Cash Flow over 5 years: stood at $46859.3 in 2021, then jumped by 1643.52% to $817000.0 in 2022, then slumped by 2041.86% to -$15.9 million in 2023, then soared by 93.67% to -$1.0 million in 2024, then jumped by 1239.9% to $11.5 million in 2025.
• The last three Free Cash Flow figures came in at $11.5 million (Q4 2025), -$1.0 million (Q4 2024), and $10.1 million (Q3 2024), per Business Quant data.